tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Balance Sheet

701 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q2 2024 were $292.07M, a decrease of -16.84% from the previous quarter. IMVT total liabilities were $40.26M for the fiscal quarter, a -21.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 23Mar 22Mar 21Mar 20Dec 18
Total Assets
$ 405.84M$ 515.23M$ 412.49M$ 109.39M$ 405.00K
Total Liabilities
$ 43.34M$ 45.74M$ 21.01M$ 15.32M$ 380.45K
Total Equity Gross Minority
$ 362.49M$ 469.82M$ 391.48M$ 94.07M$ 24.55K
Total Capitalization
$ 362.54M$ 469.82M$ 391.48M$ 94.07M$ 24.55K
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 3.42M$ 0.00-
Currency in USD

Immunovant Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis